HRTX
Heron Therapeutics Inc
Price:  
3.41 
USD
Volume:  
1,928,855.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HRTX Relative Valuation

-540.4%
Upside

As of 2024-05-29, the Relative Valuation of Heron Therapeutics Inc (HRTX) is (15.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.41 USD, the upside of Heron Therapeutics Inc based on Relative Valuation is -540.4%.

The range of the Relative Valuation is (12.97) - (15.16) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 20.7x - 28.8x 28.1x
Forward P/E multiples 24.1x - 28.2x 27.8x
Fair Price (12.97) - (15.16) (15.02)
Upside -480.4% - -544.7% -540.4%
3.41 USD
Stock Price
(15.02) USD
Fair Price

HRTX Relative Valuation - Historical P/E Data

Date P/E
2024-05-28 -6.35
2024-05-24 -6.40
2024-05-23 -6.46
2024-05-22 -6.46
2024-05-21 -6.40
2024-05-20 -6.33
2024-05-17 -5.95
2024-05-16 -5.99
2024-05-15 -5.58
2024-05-14 -5.23
2024-05-13 -5.24
2024-05-10 -5.15
2024-05-09 -5.47
2024-05-08 -5.60
2024-05-07 -5.34
2024-05-06 -5.29
2024-05-03 -4.86
2024-05-02 -4.75
2024-05-01 -4.35
2024-04-30 -4.32
2024-04-29 -4.65
2024-04-26 -4.56
2024-04-25 -4.75
2024-04-24 -4.93
2024-04-23 -5.21
2024-04-22 -4.82
2024-04-19 -4.91
2024-04-18 -5.04
2024-04-17 -5.15
2024-04-16 -5.45
2024-04-15 -5.49
2024-04-12 -5.42
2024-04-11 -5.47
2024-04-10 -5.08
2024-04-09 -5.21
2024-04-08 -5.12
2024-04-05 -5.12
2024-04-04 -4.78
2024-04-03 -4.78
2024-04-02 -4.75
2024-04-01 -5.04
2024-03-28 -5.15
2024-03-27 -5.10
2024-03-26 -5.10
2024-03-25 -5.49
2024-03-22 -5.53
2024-03-21 -5.68
2024-03-20 -5.68
2024-03-19 -5.49
2024-03-18 -5.51